Russell Investments Group
TRIB

Russell Investments Group’s Trinity Biotech TRIB Stock Holding History

Russell Investments Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,651
Closed -$735K – 3097
2019
Q2 		$735K Sell
2,651
-3,647
-58% -$1.3M ﹤0.01% 2117
2019
Q1 		$2.69M Buy
6,298
+694
+12% +$286K 0.01% 1563
2018
Q4 		$1.92M Sell
5,604
-3,354
-37% -$1.55M ﹤0.01% 1633
2018
Q3 		$5.37M Sell
8,958
-670
-7% -$437K 0.01% 1262
2018
Q2 		$7.22M Sell
9,628
-2,903
-23% -$2.09M 0.02% 1090
2018
Q1 		$9.68M Buy
12,531
+4,521
+56% +$3.7M 0.02% 997
2017
Q4 		$6.03M Buy
8,010
+4,419
+123% +$3.42M 0.01% 1235
2017
Q3 		$3.02M Buy
3,591
+540
+18% +$452K 0.01% 1545
2017
Q2 		$2.75M Buy
3,051
+496
+19% +$421K ﹤0.01% 1549
2017
Q1 		$2.28M Sell
2,555
-228
-8% -$214K ﹤0.01% 1679
2016
Q4 		$2.9M Buy
+2,783
New +$2.88M 0.01% 1600

Other funds holding TRIB

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Russell Investments Group's TRIB Position: Q3 2019 in Review

Russell Investments Group sold out of Trinity Biotech (TRIB) in Q3 2019, closing a stake of 2,651 shares — an estimated $735K sold.

Russell Investments Group first reported a position in TRIB in Q4 2016 and held it in 11 quarters. The position peaked at $9.68M in Q1 2018. 28 funds tracked by Wall St. Rank hold TRIB as of Q3 2019.

  • Russell Investments Group reported no remaining Trinity Biotech position as of Q3 2019 after selling out during the quarter.
  • Russell Investments Group sold 2,651 Trinity Biotech shares in Q3 2019, an estimated $735K.
  • Russell Investments Group first reported a position in Trinity Biotech in Q4 2016 and held it in 11 quarters.
  • Russell Investments Group's Trinity Biotech position peaked at $9.68M in Q1 2018.
  • 28 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2019.

Based on Russell Investments Group's 13F filing for Q3 2019, filed 1 Nov 2019.